ZFIN ID: ZDB-FISH-220914-5
Fish name: gria4auva43/uva43; vu17Tg; vu19Tg
Genotype: gria4auva43/uva43; vu17Tg; vu19Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by gria4auva43/uva43; vu17Tg; vu19Tg
No data available
GENE EXPRESSION
Gene expression in gria4auva43/uva43; vu17Tg; vu19Tg
RNA expression No data available
Protein expression No data available
PHENOTYPE
Phenotype in gria4auva43/uva43; vu17Tg; vu19Tg
Phenotype Conditions Figures
glioblast (sensu Vertebrata) cell death normal occurrence, normal chemical treatment by environment: 2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline Fig. 3 from Piller et al., 2021
glioblast (sensu Vertebrata) cell population proliferation normal occurrence, normal chemical treatment by environment: 2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline Fig. 3 from Piller et al., 2021
spinal cord dorsal region has fewer parts of type glioblast (sensu Vertebrata), abnormal control Fig. 3 from Piller et al., 2021
spinal cord dorsal region has number of glioblast (sensu Vertebrata), ameliorated chemical treatment by environment: 2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline Fig. 3 from Piller et al., 2021
spinal cord glial cell migration decreased process quality, abnormal control Fig. 3 from Piller et al., 2021
spinal cord glial cell migration process quality, ameliorated chemical treatment by environment: 2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline Fig. 3 from Piller et al., 2021
whole organism morphology, normal chemical treatment by environment: 2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline Fig. 3 from Piller et al., 2021
whole organism morphology, normal control Fig. 3 from Piller et al., 2021
whole organism normal length, normal chemical treatment by environment: 2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline Fig. 3 from Piller et al., 2021
whole organism normal length, normal control Fig. 3 from Piller et al., 2021

CITATIONS  (1)